Researchers find that 'peanut butter' test can help diagnose Alzheimer's disease

October 9, 2013, University of Florida

(Medical Xpress)—A dollop of peanut butter and a ruler can be used to confirm a diagnosis of early stage Alzheimer's disease, University of Florida Health researchers have found.

Jennifer Stamps, a graduate student in the UF McKnight Brain Institute Center for Smell and Taste, and her colleagues reported the findings of a small pilot study in the Journal of the Neurological Sciences.

Stamps came up with the idea of using to test for sensitivity while she was working with Dr. Kenneth Heilman, the James E. Rooks distinguished professor of neurology and health psychology in the UF College of Medicine's department of neurology.

She noticed while shadowing in Heilman's clinic that patients were not tested for their sense of smell. The ability to smell is associated with the first cranial nerve and is often one of the first things to be affected in cognitive decline. Stamps also had been working in the laboratory of Linda Bartoshuk, the William P. Bushnell presidentially endowed professor in the College of Dentistry's department of community dentistry and behavioral sciences and director of human research in the Center for Smell and Taste.

"Dr. Heilman said, 'If you can come up with something quick and inexpensive, we can do it,'" Stamps said.

She thought of peanut butter because, she said, it is a "pure odorant" that is only detected by the olfactory nerve and is easy to access.

In the study, patients who were coming to the clinic for testing also sat down with a clinician, 14 grams of peanut butter—which equals about one tablespoon—and a metric ruler. The patient closed his or her eyes and mouth and blocked one . The clinician opened the peanut butter container and held the ruler next to the open nostril while the patient breathed normally. The clinician then moved the peanut butter up the ruler one centimeter at a time during the patient's exhale until the person could detect an odor. The distance was recorded and the procedure repeated on the other nostril after a 90-second delay.

The clinicians running the test did not know the patients' diagnoses, which were not usually confirmed until weeks after the initial clinical testing.

The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril—the left nostril was impaired and did not detect the smell until it was an average of 10 centimeters closer to the nose than the right nostril had made the detection in patients with Alzheimer's disease. This was not the case in patients with other kinds of dementia; instead, these patients had either no differences in odor detection between nostrils or the right nostril was worse at detecting odor than the left one.

Of the 24 patients tested who had , which sometimes signals Alzheimer's disease and sometimes turns out to be something else, about 10 patients showed a left nostril impairment and 14 patients did not. The researchers said more studies must be conducted to fully understand the implications.

"At the moment, we can use this test to confirm diagnosis," Stamps said. "But we plan to study patients with mild cognitive impairment to see if this test might be used to predict which patients are going to get Alzheimer's disease."

Stamps and Heilman point out that this test could be used by clinics that don't have access to the personnel or equipment to run other, more elaborate tests required for a specific diagnosis, which can lead to targeted treatment. At UF Health, the peanut butter test will be one more tool to add to a full suite of clinical tests for neurological function in with memory disorders.

One of the first places in the brain to degenerate in people with Alzheimer's disease is the front part of the temporal lobe that evolved from the smell system, and this portion of the brain is involved in forming new memories.

"We see people with all kinds of memory disorders," Heilman said. Many tests to confirm a diagnosis of Alzheimer's disease or other dementias can be time-consuming, costly or invasive. "This can become an important part of the evaluation process."

Explore further: Scientists spot early signs of Alzheimer's disease

Related Stories

Scientists spot early signs of Alzheimer's disease

July 9, 2013
Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University.

Girls who eat peanut butter may improve breast health later in life​​​​​

September 26, 2013
(Medical Xpress)—Here's some news worth spreading: Girls who eat more peanut butter could improve their breast health later in life.

Seizures late in life may be an early sign of Alzheimer's disease

July 8, 2013
Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA ...

Toward an early diagnostic tool for Alzheimer's disease

August 29, 2013
Despite all the research done on Alzheimer's, there is still no early diagnostic tool for the disease. By looking at the brain wave components of individuals with the disease, Professor Tiago H. Falk of INRS's Centre Énergie ...

Mayo study seeks to pretreat Alzheimer's in effort to prevent brain damage

July 16, 2013
The day is coming when doctors will be able to diagnose and treat Alzheimer's disease before people have symptoms, and Ronald Petersen is among the doctors laying the groundwork for that future.

Alzheimer's to be diagnosed online

January 8, 2013
(Medical Xpress)—The early onset of Alzheimer's disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ).

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.